Gluconeogenesis in moderately and severely hyperglycemic patients with type 2 diabetes mellitus

Am J Physiol Endocrinol Metab. 2001 Jan;280(1):E23-30. doi: 10.1152/ajpendo.2001.280.1.E23.

Abstract

We tested the generally accepted concept that increased gluconeogenesis (GNG) and endogenous glucose production (EGP) are the main reasons for postabsorptive hyperglycemia in patients with type 2 diabetes mellitus (T2DM). GNG was measured with the (2)H(2)O method by use of both the C5-to-C2 ratio (C5/C2, with gas chromatography-mass spectrometry) and the C5-to-(2)H(2)O ratio (C5/(2)H(2)O, with isotope ratio mass spectrometry), and EGP was measured with 3-[(3)H]glucose in 27 patients with T2DM [13 with fasting plasma glucose (FPG) >10 mM and 14 with FPG <10 mM] and in 7 weight- and age-matched nondiabetic controls. The results showed 1) that GNG could be determined accurately with (2)H(2)O by using either C5/C2 or C5/(2)H(2)O; 2) that whereas after an overnight fast of 16 h, GNG was higher in the entire group of patients with T2DM than in controls (6.4 vs. 5.0 micromol. kg(-1). min(-1) or 60.4 vs. 51.4% of EGP, P < 0.02), GNG was within normal limits (less than the mean +/- 2 SD of controls or <65.3%) in 11/14 (79%) patients with mild to moderate hyperglycemia (FPG <10 mM) and in 5/13 (38%) of patients with severe hyperglycemia (FPG 10-20 mM); 3) that elevated GNG in T2DM was associated with a 43% decrease in prehepatic insulin secretion, i.e., with hepatic insulin deficiency; and 4) that FPG correlated significantly with glucose clearance (insulin resistance) (r = 0.70) and with GNG (r = 0.50) or EGP (r = 0.45). We conclude 1) that peripheral insulin resistance is at least as important as GNG (and EGP) as a cause of postabsorptive hyperglycemia in T2DM and 2) that GNG and EGP in T2DM are increased under conditions of significant hepatic insulin deficiency and thus probably represent a late event in the course of T2DM.

Publication types

  • Clinical Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aged
  • Blood Glucose / biosynthesis
  • Deuterium
  • Diabetes Mellitus, Type 2 / metabolism*
  • Fasting / physiology
  • Fatty Acids, Nonesterified / blood
  • Female
  • Glucagon / blood
  • Gluconeogenesis / physiology*
  • Glucose / pharmacokinetics
  • Glycolysis / physiology
  • Human Growth Hormone / blood
  • Humans
  • Hydrocortisone / blood
  • Hyperglycemia / metabolism*
  • Insulin / metabolism
  • Insulin Resistance / physiology
  • Insulin Secretion
  • Ketone Bodies / blood
  • Male
  • Middle Aged
  • Tritium

Substances

  • Blood Glucose
  • Fatty Acids, Nonesterified
  • Insulin
  • Ketone Bodies
  • Tritium
  • Human Growth Hormone
  • Glucagon
  • Deuterium
  • Glucose
  • Hydrocortisone